Wills Eye Institute and Thomas Jefferson University have partnered to create the Wills Vision Research Center at Jefferson here, according to a press release.
Month: May 2011
Michael R. Redmond, MD, Receives Outstanding Advocate Award From The American Academy Of Ophthalmology
The American Academy of Ophthalmology (Academy) has presented the Outstanding Advocate Award to Michael R. Redmond, MD, for his more than 30 years of involvement with advocacy on behalf of ophthalmologists and their patients and for his many contributi…
Boatright Begins Term As ARVO President
Jeffrey H. Boatright, PhD, FARVO (Emory University School of Medicine) is the new president of the Association of Research in Vision and Ophthalmology (ARVO). He succeeds J. Mark Petrash, PhD, FARVO (University of Colorado), whose one-year term ended i…
Smoking Strongly Linked To Age-Related Blindness
When Kern and Harbach wrote “Smoke Gets in Your Eyes” nearly 80 years ago, they were playing bards, not doctors. But a new study shows that smokers are at substantially increased risk for developing age-related blindness.
Selenium Effective for Mild Graves’ Orbitopathy
A twice-daily supplement of selenium helped symptoms and improved quality of life in European patients with mild Graves’ orbitopathy, doctors report in the May 19 New England Journal of Medicine. Reuters Health Information
Selenium Eases Graves’ Eye Symptoms (CME/CE)
(MedPage Today) — Selenium treatment of ocular symptoms in patients with Graves’ disease significantly improved their quality of life, European researchers found.
Improved Form Of Vitamin A May Help In Preventing Blindness From Age-Related Macular Degeneration And Stargardt’s Disease
Slowing down the aggregation or “clumping” of vitamin A in the eye may help prevent vision loss caused by macular degeneration, research from Columbia University Medical Center has found…
Modified vitamin A drug may help prevent age-related macular degeneration
Slowing down the aggregation or “clumping” of vitamin A in the eye may help prevent vision loss caused by macular degeneration, research from Columbia University Medical Center has found.
Paramax Moves Closer To FDA Approval
Paradigm Medical Industries, Inc. (OTC.PK: PDMI) announced today that it had received notification from its Italian partner, Costruzione Strumenti Oftalmici (CSO), which manufactures the Paramax, that it has provided 26 pages and 24 attachments to the …
New Multidisciplinary Center Takes Innovative Approach To Vision Research
Wills Eye Institute and Thomas Jefferson University Establish the Wills Vision Research Center at Jefferson
New Multidisciplinary Center Takes Innovative Approach To Vision Research
Wills Eye Institute and Thomas Jefferson University Establish the Wills Vision Research Center at Jefferson
New Multidisciplinary Center Takes Innovative Approach To Vision Research
Wills Eye Institute and Thomas Jefferson University Establish the Wills Vision Research Center at Jefferson
New Multidisciplinary Center Takes Innovative Approach To Vision Research
Wills Eye Institute and Thomas Jefferson University Establish the Wills Vision Research Center at Jefferson
Mpex Pharmaceuticals, Synteract partner for cystic fibrosis fundraising event
Synteract, Inc., a full-service, global contract research organization, and Mpex Pharmaceuticals, a biopharmaceutical company developing new therapies to combat the growing issue of antibiotic resistance, have partnered for the second annual Great Stri…
Improved Form Of Vitamin A May Help In Preventing Blindness From Age-Related Macular Degeneration And Stargardt’s Disease
Slowing down the aggregation or “clumping” of vitamin A in the eye may help prevent vision loss caused by macular degeneration, research from Columbia University Medical Center has found.
Glaucoma Laser Surgery
Featured Article
Avedro Update: Company Completes U.S. Phase III Study of Microwave Treatment for Progressive Keratoconus and Ectasia after Refractive Surgery
I have been following the progress of Avedro since I first learned about the formation of the company back in May 2009. Now the company has announced completion of the one-year follow up visits of patients enrolled in its two…
Alimera Sciences Says Iluvien Effective at 3 Years
Iluvien, a sustained release drug-delivery system for the treatment of diabetic macular edema, may be getting closer to possible FDA approval. The parent company, Alimera Sciences has resubmitted additional safety and efficacy data as requested by the FDA last year. …
Researchers Work On Preventing Blindness From Age-Related Macular Degeneration And Stargardt’s Disease
Slowing down the aggregation or “clumping” of vitamin A in the eye may help prevent vision loss caused by macular degeneration, research from Columbia University Medical Center has found…
AMA Is Reseller of Cloud-Based Medical Software
A limited menu of programs for medical records, electronic prescribing, patient registries, and the like simplifies the selection process, although some health IT experts question the choice of products. Medscape Medical News